ESR1 and breast carcinoma: Hormone replacement therapies, aiming at restoring the pre-menopausal circulating levels of estrogens have been previously used to counteract the deleterious effects of menopause but have however been associated with an increased risk in breast cancer, in a manner that depends on the classical estrogen receptors.